Tag: acute myeloid leukemia

  • Nation & World

    New approach to slowing aggressive leukemia

    Compounds that degrade proteins and block cell growth developed by Harvard researchers hold promise as a treatment for more types of cancer.

    4 minutes
    Research assistants David Miyamoto (from left) and Nicole Curnutt work with Associate Professor Christina Woo
  • Nation & World

    Learning why cancer drugs work (or don’t)

    Assistant Professor Brian Liau of the Chemistry and Chemical Biology Department has answered the question of why some new drugs for acute myeloid leukemia don’t work by combining CRISPR gene editing with small-molecule inhibitor treatments in a technique he calls CRISPR-suppressor scanning.

    5 minutes
    Professor sits in front of a white board
  • Nation & World

    Progress against acute myeloid leukemia

    A new drug compound developed by researchers at Massachusetts General Hospital and the Harvard Stem Cell Institute to treat acute myeloid leukemia is gentle enough to use with patients too frail to endure chemotherapy.

    3 minutes
  • Nation & World

    Collaboration to develop cancer therapeutics

    The Blavatnik Biomedical Accelerator will collaborate with Merck to develop small-molecule therapy for the most common form of acute leukemia.

    3 minutes
  • Nation & World

    Inroads against leukemia

    A molecule isolated from sea sponges and later synthesized in the lab can halt the growth of cancerous cells and could open the door to a new treatment for leukemia, according to a team of Harvard researchers.

    6 minutes
  • Nation & World

    Developing cancer drugs

    Harvard Stem Cell Institute researchers have identified in the most aggressive forms of cancer a gene known to regulate embryonic stem cell self-renewal, beginning a creative search for a drug that can block its activity.

    4 minutes